Home › Trial NCT07335380
Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma
- Trial IDNCT07335380
- StatusNot Yet Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorNYU Langone Health
- Enrollment30
- Start date2026-04
- ConditionsOral Cavity Squamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.